(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 455.20%4.82M | 1,808.68%2.11M | -146.01%-820.22K | 21.00%6.54M | -33.42%6M | -34.61%-1.36M | 112.58%110.79K | 203.58%1.78M | 30.08%5.4M | 1,383.42%9.01M |
Net income from continuing operations | -205.14%-423.81K | -34.30%1.24M | 1,669.72%2.39M | 49.93%2.81M | -74.90%677.65K | 218.55%403.09K | 369.91%1.88M | -171.65%-152.37K | 287.66%1.88M | 414.96%2.7M |
Operating gains losses | -248.37%-151.49K | 234.30%138.23K | 222.85%228.71K | 15.64%-369.2K | 1.06%-293.63K | -122.16%-43.48K | -241.22%-102.92K | 117.28%70.84K | -291.31%-437.63K | -50.19%-296.79K |
Depreciation and amortization | --0 | 38.56%120.18K | 34.18%118.72K | 2.44%374.87K | -8.01%97K | 12.27%102.66K | 0.30%86.73K | 7.15%88.48K | 1.82%365.93K | -2.18%105.44K |
Asset impairment expenditure | ---- | ---- | ---- | --72.85K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --0 | -50.00%23.82K | --0 | -12.15%232.93K | -36.71%51.68K | 11,186,100.00%111.86K | -72.87%47.64K | 175.04%21.75K | 2,039.04%265.13K | 776.42%81.66K |
Deferred tax | 5.26%60K | 132.26%432K | 5.88%-144K | 84.72%-66K | -457.14%-156K | 311.11%57K | 151.24%186K | -992.86%-153K | -236.71%-432K | -315.38%-28K |
Other non cashItems | -224.41%-32.26K | -1,597,050.00%-31.94K | 46,766,100.00%467.66K | 100.16%15.87K | ---10.07K | --25.93K | --2 | ---1 | -962.43%-9.95M | ---- |
Change In working capital | 369.95%5.36M | 109.81%195.18K | -303.61%-3.88M | -6.83%3.47M | -13.56%5.54M | -114.10%-1.99M | -1,182.01%-1.99M | 219.17%1.91M | 21.27%3.72M | 799.93%6.4M |
-Change in receivables | 558.63%4.72M | 69.95%-868.5K | -148.77%-3.07M | 166.18%5.96M | 139.07%3.58M | -13.34%-1.03M | -1,385.10%-2.89M | 639.38%6.3M | -811.68%-9M | -25.89%-9.17M |
-Change in inventory | 69.14%584.75K | 67.51%1.68M | -278.52%-972.13K | 176.55%2.71M | 190.40%818.66K | 126.38%345.72K | 254.89%1M | 129.18%544.54K | -147.93%-3.54M | 113.32%281.91K |
-Change in prepaid assets | -246.18%-195.42K | -141.64%-86.68K | 63.99%-52.85K | 24.43%-73.79K | -242.02%-78.76K | -250.29%-56.45K | 229.30%208.18K | 26.70%-146.75K | 5.14%-97.63K | -84.46%55.46K |
-Change in payables and accrued expense | 130.85%376.5K | -73.79%-562.03K | 104.26%204.46K | -131.74%-5.17M | -92.28%1.17M | -193.91%-1.22M | -269.27%-323.39K | -1,146.09%-4.8M | 192.11%16.29M | 87.04%15.19M |
-Change in other working capital | ---125.86K | 166.00%32.09K | -43.57%7.86K | -42.40%40.2K | ---- | ---- | --12.06K | --13.93K | 689.05%69.78K | 411.27%48.46K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 462.13%4.82M | 1,808.65%2.11M | -146.01%-820.22K | 242.23%6.54M | 705.28%5.97M | -32.03%-1.33M | 112.58%110.8K | 203.58%1.78M | -210.98%-4.6M | -38.20%-987.09K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -203.01%-102.8K | -2,103.70%-933.33K | -668.81%-232.35K | -134.03%-58.62K | 43.09%-97.45K | -8.54%-33.93K | -42.35K | 71.64%-30.22K | 814.20%172.27K |
Net PPE purchase and sale | --0 | -203.01%-102.8K | -2,103.70%-933.33K | -668.81%-232.35K | -134.03%-58.62K | 43.09%-97.45K | -8.54%-33.93K | ---42.35K | 67.95%-30.22K | 814.20%172.27K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -203.01%-102.8K | -2,103.70%-933.33K | -668.81%-232.35K | -134.03%-58.62K | 43.09%-97.45K | -8.54%-33.93K | ---42.35K | 71.64%-30.22K | 814.20%172.27K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -96.65%37.8K | -92.95%18.77K | 99.55%-15.77K | -223.25%-4.81M | -367.17%-2.72M | 36.00%1.13M | 12.67%266.33K | -291.67%-3.49M | 368.94%3.9M | 1,604.90%1.02M |
Net issuance payments of debt | --0 | -146.93%-124.98K | 98.92%-37.71K | -213.10%-3.77M | -301.79%-1.65M | 73.70%1.1M | 240.65%266.33K | -293.66%-3.49M | 309.16%3.33M | 1,265.34%817.81K |
Proceeds from stock option exercised by employees | 46.52%37.8K | --143.75K | --21.94K | -79.35%76.8K | 5,100,100.00%51K | -86.77%25.8K | --0 | --0 | 162.87%371.95K | -100.11%-1 |
Net other financing activities | ---- | ---- | ---- | -1,300.00%-1.12M | ---- | ---- | ---- | ---- | ---80K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -96.65%37.8K | -92.95%18.77K | 99.55%-15.77K | -232.78%-4.81M | -468.56%-2.72M | 36.00%1.13M | 12.67%266.33K | -291.67%-3.49M | 349.65%3.62M | 1,190.90%737.81K |
Net cash flow | ||||||||||
Beginning cash position | 266.24%4.37M | 178.34%2.36M | 57.85%4.11M | -27.68%2.6M | -66.57%894.35K | -60.51%1.19M | -77.11%849.27K | -27.68%2.6M | 249.84%3.6M | -39.28%2.68M |
Current changes in cash | 1,725.03%4.86M | 491.70%2.03M | -1.24%-1.77M | 248.83%1.49M | 4,249.75%3.2M | 14.32%-298.78K | 150.78%343.2K | -1,871.12%-1.75M | -138.82%-1M | 90.45%-77.01K |
Effect of exchange rate changes | 1,788.84%23.91K | -1,044.77%-19.6K | 404.37%22.3K | 133.24%14.07K | 258.38%20.74K | -122.99%-1.42K | 122.24%2.08K | -171.77%-7.33K | 150.65%6.03K | 554.01%5.79K |
End cash Position | 934.72%9.25M | 266.24%4.37M | 178.34%2.36M | 57.85%4.11M | 57.85%4.11M | -66.57%894.35K | -60.51%1.19M | -77.11%849.27K | -27.68%2.6M | -27.68%2.6M |
Free cash from | 437.41%4.82M | 2,517.31%2.01M | -200.75%-1.75M | 236.28%6.31M | 826.05%5.92M | -21.12%-1.43M | 108.43%76.87K | 201.12%1.74M | -214.66%-4.63M | -10.36%-814.82K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data